U.S. Chronic Obstructive Pulmonary Disease Therapies Markets

 


This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely bronchodilators, anti-inflammatories and other emerging therapeutics. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

U.S. Chronic Obstructive Pulmonary Disease Therapies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Chronic Obstructive Pulmonary Disease Therapies Markets, IntroductionOverviewScope And SegmentationDisease DefinitionSymptomsRisk FactorsDiagnosisPrevention And TreatmentDrug Delivery MethodsDisease Prevalence And MortalitySocietal Economic BurdenChallengesMarket DriversMarket RestraintsMarket DynamicsDemand AnalysisMarket And Technology TrendsStrategic RecommendationsStrategies OverviewStrategic Recommendations For Market Challenge 1Strategic Recommendations For Market Challenge 2Strategic Recommendations For Market Challenge 3Strategic Recommendations For Market Challenge 4 Frost & Sullivan Market Engineering AwardsMarket Engineering Leadership Award: Boehringer IngelheimTechnology Leadership Award: GlaxoSmithKline Product Differentiation Innovation Award: Sheffield Pharmaceuticals Inc.Business Development Strategy Award: Dey Inc.Technology Innovation Award: Sepracor Inc.U.S. Chronic Obstructive Pulmonary Disease Therapies Markets, Bronchodilator Therapies MarketOverviewIntroductionMarket DriversMarket RestraintsMarket Engineering AnalysisRevenue ForecastCompetitive AnalysisCompetitive StructureMarket Share AnalysisShort-Acting Beta2 Agonist MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProducts Analysis-ExistingProduct Analysis-EmergingLong-Acting Beta2 Agonist MarketIntroductionMarket Engineering AnalysisRevenue ForecastsPricing TrendsCompetitive StructureMarket Share AnalysisProducts Analysis-ExistingProduct Analysis-EmergingAnticholinergics MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProducts Analysis-ExistingProduct Analysis-EmergingMethylxanthines MarketIntroductionMarket Engineering AnalysisRevenue ForecastsPricing TrendsCompetitive StructureProducts Analysis-ExistingU.S. Chronic Obstructive Pulmonary Disease Therapies Markets, Anti-Inflammatory Therapies MarketOverviewIntroductionMarket DriversMarket RestraintsMarket Engineering AnalysisRevenue ForecastCompetitive AnalysisCompetitive StructureMarket Share AnalysisInhaled Corticosteroids MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProducts Analysis-ExistingProduct Analysis-EmergingAnti-Leukotrienes MarketIntroductionMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProducts Analysis-ExistingProduct Analysis-EmergingOther Emerging Anti-Inflammatory Therapeutics MarketIntroductionRevenue ForecastCompetitive StructureProduct Analysis-EmergingU.S. Chronic Obstructive Pulmonary Disease Therapies Markets, Other Emerging COPD Therapies MarketOverviewIntroductionCompetitive StructureProduct Analysis-EmergingU.S. Chronic Obstructive Pulmonary Disease Therapies Markets, Decision Support DatabaseCausal FactorsMortality due to Respiratory DiseasePrevalence of Male SmokersPrevalence of Female SmokersTotal Prevalence of SmokersHealthcare InfrastructureNumber of HospitalsNumber of PhysiciansDemographicsMale Population over 65 years of AgeFemale Population over 65 years of AgeTotal Population over 65 years of Age




Related Research

Release Date : 11-Aug-17

Region : North America

Release Date : 10-Aug-17

Region : North America

Release Date : 09-Aug-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.